We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Celsis Adds Drug Development Services to Growing Services Portfolio

News   Sep 13, 2007

 
Celsis Adds Drug Development Services to Growing Services Portfolio
 
 
 

RELATED ARTICLES

More Effective Drug Combination Regimens to Treat TB Faster

News

UCLA researchers have identified a way to significantly reduce the duration of tuberculosis treatment using an approach called "artificial intelligence-parabolic response surface."

READ MORE

Statins’ Potential to Treat MS Unrelated to Lowering Cholesterol

News

The widely prescribed statin, simvastatin, can medically help patients with secondary progressive Multiple Sclerosis (SPMS) - for reasons that might be unrelated to the drug’s intended cholesterol lowering affects, a UCL study has found.

READ MORE

Drug Developed to Overcome Ibrutinib Resistance in Mantle Cell Lymphoma

News

A study at The University of Texas MD Anderson Cancer Center demonstrated how a small molecule drug discovered at the institution may help overcome resistance to treatment with ibrutinib in patients with mantle cell lymphoma.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE